Researching New Methods of Screening for Adverse Pregnancy Outcome: Lessons from Pre-eclampsia
article has not abstract
Vyšlo v časopise:
Researching New Methods of Screening for Adverse Pregnancy Outcome: Lessons from Pre-eclampsia. PLoS Med 9(7): e32767. doi:10.1371/journal.pmed.1001274
Kategorie:
Essay
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001274
Souhrn
article has not abstract
Zdroje
1. World Health Organization (2011) World health statistics 2011. Geneva: WHO Press.
2. National Collaborating Centre for Women's and Children's Health (2008) NICE guideline: antenatal care. London: RCOG Press.
3. YuCK, SmithGC, PapageorghiouAT, CachoAM, NicolaidesKH (2005) An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193: 429–436.
4. AlfirevicZ, StampalijaT, GyteGM (2010) Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database Syst Rev (8) CD001450.
5. National Collaborating Centre for Women's and Children's Health (2011) NICE guideline: hypertension in pregnancy. London: RCOG Press.
6. DuleyL, Henderson-SmartDJ, MeherS, KingJF (2007) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev (2) CD004659.
7. ChurchillD, DuleyL (2002) Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database Syst Rev (3) CD003106.
8. KoopmansCM, BijlengaD, GroenH, VijgenSM, AarnoudseJG, BekedamDJ, et al. (2009) Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374: 979–988.
9. LiuS, JosephKS, ListonRM, BartholomewS, WalkerM, LeonJA, et al. (2011) Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 118: 987–994.
10. TuffnellDJ, JankowiczD, LindowSW, LyonsG, MasonGC, RussellIF, et al. (2005) Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG 112: 875–880.
11. SmithGC (2010) First-trimester determination of complications of late pregnancy. JAMA 303: 561–562.
12. LawnJE, BlencoweH, PattinsonR, CousensS, KumarR, IbiebeleI, et al. (2011) Stillbirths: where? when? why? How to make the data count? Lancet 377: 1448–1463.
13. SmithGC, ShahI, WhiteIR, PellJP, CrossleyJA, et al. (2007) Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG 114: 705–714.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- HIV Treatment as Prevention: Issues in Economic Evaluation
- HIV Treatment as Prevention: The Utility and Limitations of Ecological Observation
- Consequences of Gestational Diabetes in an Urban Hospital in Viet Nam: A Prospective Cohort Study
- HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes